Skip to main content
. 2011 Feb 11;103(5):384–397. doi: 10.1093/jnci/djq549

Table 2.

Multiple logistic regression models assessing characteristics associated with specialty physicians who refer or enroll patients in clinical trials (N = 1533)*

Characteristic Medical and radiation oncologists (n = 721)
Surgeons (n = 794)
Adjusted OR (95% CI) Adjusted percentage (95% CI) P§ Adjusted OR (95% CI) Adjusted percentage (95% CI) P§
Physicians
    Specialty
        Medical oncology 5.2 (2.8 to 9.4) 87.9 (84.9 to 91.0) <.001 .010
        Radiation oncology 1.00 (referent) 66.2 (59.1 to 73.3)
        General surgery 1.00 (referent) 31.9 (27.8 to 36.0)
        Colorectal surgery 1.0 (0.5 to 2.0) 31.3 (19.6 to 43.1)
        Thoracic surgery 1.3 (0.7 to 2.2) 35.9 (27.2 to 44.6)
        Surgical oncology 3.9 (1.8 to 8.6) 58.3 (43.2 to 73.3)
        Other surgical subspecialty 2.1 (0.8 to 5.5) 46.0 (27.8 to 64.2)
    Age, y
        <50 1.7 (1.0 to 3.1) 82.7 (78.7 to 86.7) .203 1.2 (0.7 to 1.9) 36.6 (31.8 to 41.4) .413
        50–59 1.5 (0.8 to 2.8) 81.4 (76.8 to 86.1) 0.9 (0.5 to 1.5) 31.9 (26.7 to 37.2)
        ≥60 1.00 (referent) 76.0 (69.4 to 82.6) 1.00 (referent) 33.9 (27.0 to 40.7)
    Sex
        Male 1.00 (referent) 79.6 (76.2 to 82.9) .068 1.00 (referent) 34.3 (30.8 to 37.8) .726
        Female 1.8 (1.0 to 3.3) 86.0 (80.6 to 91.3) 1.1 (0.6 to 2.1) 36.2 (26.0 to 46.4)
    US or Canadian medical school graduate
        Yes 1.00 (referent) 79.9 (76.7 to 83.2) .136 1.00 (referent) 34.0 (30.5 to 37.5) .355
        No 1.6 (0.9 to 3.0) 85.1 (79.6 to 90.7) 1.3 (0.7 to 2.4) 38.9 (28.7 to 49.1)
Practice setting
    Income increases as a result of enrolling patients on clinical trials
        Yes 1.9 (0.7 to 5.1) 87.0 (78.3 to 95.6) .214 0.9 (0.3 to 2.9) 33.5 (14.6 to 52.5) .919
        No 1.00 (referent) 80.3 (77.3 to 83.4) 1.00 (referent) 34.5 (31.2 to 37.9)
    Practice type
        Office based, solo 0.3 (0.1 to 0.6) 65.5 (53.8 to 77.2) .018 0.8 (0.4 to 1.6) 32.5 (23.2 to 41.8) .673
        Office based, group 0.8 (0.4 to 1.4) 81.0 (76.4 to 85.6) 0.8 (0.5 to 1.3) 32.9 (27.0 to 38.7)
        Hospital based 1.00 (referent) 83.8 (79.6 to 88.0) 1.00 (referent) 36.0 (31.2 to 40.8)
    Practice size, No. of physicians
        1–5 1.00 (referent) 78.4 (74.3 to 82.5) .290 1.00 (referent) 32.2 (27.6 to 36.9) .251
        6–10 1.6 (0.8 to 3.1) 84.0 (77.7 to 90.4) 1.1 (0.6 to 1.8) 33.0 (25.7 to 40.4)
        11–20 1.7 (0.6 to 4.4) 84.5 (75.3 to 93.6) 1.8 (0.9 to 3.5) 42.6 (31.4 to 53.8)
        >20 2.4 (0.8 to 7.3) 88.0 (79.3 to 96.7) 1.5 (0.9 to 2.4) 38.8 (31.1 to 46.4)
    Study site
        Five large HMOs 1.00 (referent) 83.0 (73.9 to 92.0) .129 1.00 (referent) 46.9 (34.4 to 59.3) .004
        Northern California counties 1.0 (0.4 to 2.6) 82.6 (76.9 to 88.4) 0.5 (0.3 to 1.0) 34.3 (28.1 to 40.5)
        Los Angeles County 0.8 (0.3 to 2.1) 80.2 (74.4 to 85.9) 0.4 (0.2 to 0.9) 30.9 (24.4 to 37.3)
        State of Alabama 1.1 (0.4 to 3.4) 84.2 (77.4 to 91.1) 0.3 (0.1 to 0.7) 25.0 (17.7 to 32.2)
        State of Iowa 1.0 (0.3 to 3.1) 83.0 (74.8 to 91.1) 1.0 (0.4 to 2.6) 46.6 (32.2 to 61.1)
        State of North Carolina 1.0 (0.3 to 3.2) 83.2 (74.5 to 91.8) 0.9 (0.4 to 2.1) 45.6 (36.4 to 54.9)
        Veteran’s Administration 0.3 (0.1 to 0.8) 65.9 (55.0 to 76.9) 0.4 (0.1 to 1.0) 29.0 (18.2 to 39.9)
    Practice affiliated with a CCOP
        Yes 2.1 (1.2 to 3.7) 86.1 (81.7 to 90.5) .016 1.4 (1.0 to 2.0) 38.3 (32.6 to 44.0) .094
        No 1.00 (referent) 77.8 (73.9 to 81.7) 1.00 (referent) 32.6 (28.6 to 36.6)
    Practice affiliated with an NCI-designated cancer center
        Yes 2.8 (1.2 to 6.4) 89.7 (83.5 to 95.8) .023 1.7 (1.1 to 2.6) 41.4 (34.9 to 47.9) .010
        No 1.00 (referent) 79.2 (75.9 to 82.5) 1.00 (referent) 31.6 (27.7 to 35.5)
Physician practice style
    Percentage of patients in managed care, quartiles
        0–20 0.9 (0.4 to 1.9) 79.6 (73.8 to 85.4) .759 1.7 (0.9 to 2.9) 37.5 (30.1 to 44.8) .190
        21–49 1.3 (0.5 to 3.3) 83.8 (77.6 to 90.0) 1.8 (1.0 to 3.4) 39.4 (31.6 to 47.1)
        50–78 0.9 (0.4 to 2.0) 79.9 (73.8 to 86.1) 1.5 (0.9 to 2.5) 36.1 (30.0 to 42.3)
        79–100 1.00 (referent) 80.8 (74.0 to 87.7) 1.00 (referent) 29.1 (23.4 to 34.8)
    Teaches medical students and/or residents
        Yes 2.7 (1.5 to 5.0) 87.4 (83.2 to 91.7) .003 1.6 (1.1 to 2.4) 38.4 (33.7 to 43.1) .019
        No 1.00 (referent) 75.8 (71.2 to 80.4) 1.00 (referent) 30.1 (25.2 to 35.0)
    Attends tumor board meetings
        Weekly 1.1 (0.5 to 2.5) 82.7 (79.3 to 86.2) .076 2.9 (1.8 to 4.6) 42.3 (36.3 to 48.3) <.001
        Monthly 0.6 (0.2 to 1.3) 74.3 (67.6 to 81.1) 2.1 (1.3 to 3.5) 36.6 (30.8 to 42.3)
        Quarterly or less frequently 1.00 (referent) 81.7 (72.9 to 90.5) 1.00 (referent) 23.9 (18.3 to 29.5)
    No. of colorectal or lung cancer patients seen per month
        <5 1.00 (referent) 75.2 (66.5 to 83.9) .400 1.00 (referent) 28.7 (24.7 to 32.8) <.001
        5–9 1.8 (0.9 to 3.8) 82.6 (76.8 to 88.3) 2.0 (1.3 to 3.3) 41.8 (33.5 to 50.1)
        10–19 1.9 (0.8 to 4.3) 82.9 (77.3 to 88.5) 2.1 (1.2 to 3.7) 42.6 (32.7 to 52.5)
        ≥20 1.5 (0.7 to 3.2) 80.4 (75.9 to 84.9) 5.1 (2.3 to 11.3) 60.1 (45.2 to 75.1)
    Time spent with a newly diagnosed cancer patient, min
        <60 1.00 (referent) 81.5 (76.2 to 86.8) .792 1.00 (referent) 34.9 (31.2 to 38.7) .584
        ≥60 0.9 (0.5 to 1.6) 80.6 (77.1 to 84.1) 0.87 (0.5 to 1.4) 32.7 (25.5 to 39.8)
*

— = not applicable; CCOP = Community Clinical Oncology Program; CI = confidence interval; HMO = health maintenance organization; NCI = National Cancer Institute; OR = odds ratio.

Adjusted using multiple logistic regression for all other characteristics in table.

Adjusted using predictive margins for all other characteristics in table.

§

Based on an overall Wald χ2 test for association obtained from the logistic regression models (two-sided).

Includes office-based HMOs, community health centers, and other (a questionnaire item)

Group Health Cooperative of Puget Sound, Harvard Pilgrim Health Care, Henry Ford Health System, Kaiser Permanente Northwest, and Kaiser Permanente Hawaii.